Results 141 to 150 of about 157,236 (308)
Small Bowel Lesions and Bleeding Risk in Hemodialysis Patients: A Narrative Review
ABSTRACT Background Gastrointestinal bleeding is very common among hemodialysis patients. This high bleeding risk is caused by uremic platelet dysfunction, vascular fragility, intradialytic hemodynamic instability, and widespread antithrombotic therapy.
Andreas Smyrlis +3 more
wiley +1 more source
Monovalent antibody treatment of von Willebrand disease. [PDF]
O'Donnell JS.
europepmc +1 more source
We carried out proteomic analysis of serum extracellular vesicles to identify biomarkers predictive of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis B receiving nucleos(t)ide analog therapy. Candidate proteins identified through proteomic analysis were subsequently quantified in serum by ELISA.
Emi Sometani +21 more
wiley +1 more source
Past, Present, and Future of von Willebrand Disease. [PDF]
McGrath M, Weyand AC.
europepmc +1 more source
ABSTRACT Aim The therapeutic significance of recombinant a disintegrin‐like and metalloprotease with thrombospondin type 1 motif 13 (rADAMTS13) in acute‐on‐chronic liver failure (ACLF) remains unclear. We aimed to investigate the therapeutic effects of rADAMTS13 in a murine model of ACLF‐like liver injury.
Jun‐ichi Hanatani +9 more
wiley +1 more source
Comment on "Postpartum well-being in hemophilia carriers and women with von Willebrand disease". [PDF]
Majluf-Cruz A.
europepmc +1 more source
ABSTRACT Borderline prolongation of routine clotting assays—particularly the activated partial thromboplastin time (aPTT)—is a common interpretative challenge in laboratory hematology. These reproducible but mildly prolonged results often lie just beyond the upper reference limit and can trigger unnecessary follow‐up, delays, or misinterpretation ...
Nikolaos Androulakis +3 more
wiley +1 more source
Menstrual outcomes are frequently overlooked in von Willebrand disease trials. [PDF]
O'Donnell M +10 more
europepmc +1 more source
ABSTRACT Background Hemophilia A, an X‐linked bleeding disorder caused by pathogenic variants in the F8 gene, requires precise genetic diagnosis for optimal management. Conventional stepwise sequence and copy number variation (CNV) analyses are time‐consuming and may leave some cases unresolved.
Enise Avci Durmusalioglu +13 more
wiley +1 more source

